Journal of Laboratory Physicians
Home About us Ahead of print Current issue Back issues Subscribe Instructions Contact Login 
Wide layoutNarrow layoutPrint this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 


 
   Table of Contents     
CASE REPORT
Year : 2016  |  Volume : 8  |  Issue : 2  |  Page : 112-115  

Sertoliform endometrioid tumor of ovary presenting as torsion


Department of Pathology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India

Date of Web Publication20-Apr-2016

Correspondence Address:
Dr. Prathiksha Pai
Department of Pathology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2727.180792

Rights and Permissions
   Abstract 

Sertoliform endometrioid carcinoma of the ovary (SEC) is an uncommon variant that bears histologic similarity to sertoli and sertoli-leydig cell tumors. We report an interesting case of SEC in a 55-year-old female with a left ovarian mass with torsion. Histology revealed an SEC, featuring foci of typical endometrioid carcinoma, and areas composed of uniform, small, hollow tubules lined by columnar cells with apical cytoplasm. Tumor cells were strongly immunoreactive for EMA and cytokeratin but negative for inhibin; thus, confirming the diagnosis of SEC ovary. Recognition of this tumor is important as it is a well-differentiated, low-grade malignancy that displays good prognosis when confined to the ovary.

Keywords: Endometrioid tumor, ovary, sertoliform variant


How to cite this article:
Pai P, Jadhav MN, Patil RK, Kittur SK. Sertoliform endometrioid tumor of ovary presenting as torsion. J Lab Physicians 2016;8:112-5

How to cite this URL:
Pai P, Jadhav MN, Patil RK, Kittur SK. Sertoliform endometrioid tumor of ovary presenting as torsion. J Lab Physicians [serial online] 2016 [cited 2019 Jun 17];8:112-5. Available from: http://www.jlponline.org/text.asp?2016/8/2/112/180792


   Introduction Top


Sertoliform endometrioid carcinoma of the ovary (SEC) is an uncommon variant that bears histologic similarity to sertoli and sertoli-Leydig cell tumors (SLTs). [1] This morphologic similarity may serve as a potential diagnostic pitfall for the pathologist. Recognition of this tumor is important as it is a well-differentiated, low-grade malignancy that displays a good prognosis when confined to the ovary. [1],[2]


   Case Report Top


A 55-year-old postmenopausal female patient presented with mass per abdomen since 2 years and pain for 2 days. There was no history of bleeding per vagina. No signs of virilization were noted clinically. Per-abdomen tender mass was felt in left hypogastric and iliac fossa. Ultrasonography showed multicystic lesion measuring 12 cm × 11 cm in the left ovary [Figure 1]. Intraoperatively, left ovarian cyst showed torsion with rupture of cyst wall. Total hysterectomy with bilateral salpingo-oophorectomy was done.
Figure 1: Ultrasonography showing multicystic lesion measuring 12 cm × 11cm in the left ovary


Click here to view


On gross examination, ovary weighed 550 g, measured 13 cm × 11 cm × 7 cm, showed solid and cystic areas on cut section [Figure 2]. Microscopy showed round to solid tubules lined by pseudostratified columnar epithelium with elongated nuclei resembling sertoli tumor-like pattern along with conventional endometrioid tumor [Figure 3], [Figure 4], [Figure 5]. Utero-cervix and rest of adnexa were unremarkable. A histopathological diagnosis of SEC of left ovary was made.
Figure 2: Left ovarian tumor with cut surface showing cystic and gray-white solid areas. Inset: Outer surface showing blackish areas due to torsion


Click here to view
Figure 3: Microphotograph showing sertoliform endometrioid carcinoma showing tubules and tightly packed nests of tumor cells separated by fibrous stroma. Individual tumor cells having vesicular nuclei, prominent nucleoli, and moderate cytoplasm (H and E, ×400)


Click here to view
Figure 4: Microphotograph showing foci of conventional endometrioid carcinoma (H and E, ×400)


Click here to view
Figure 5: Microphotograph showing foci of conventional endometrioid carcinoma and sertoli cell tumor-like pattern (H and E, ×200)


Click here to view


Immunohistochemistry (IHC) showed tumor cells strongly immunoreactive for epithelial membrane antigen (EMA), cytokeratin (CK) but negative for inhibin [Figure 6], [Figure 7], [Figure 8], thus confirming the diagnosis of SEC of left ovary.
Figure 6: Sertoliform endometrioid carcinoma showing cytokeratin positivity (immunohistochemistry, ×200)


Click here to view
Figure 7: Sertoliform endometrioid carcinoma showing epithelial membrane antigen positivity (immunohistochemistry, ×400)


Click here to view
Figure 8: Sertoliform endometrioid carcinoma showing inhibin negativity (immunohistochemistry, ×400)


Click here to view



   Discussion Top


Endometrioid carcinoma of ovary resembling sex cord-stromal tumor is a rare variant of endometrioid adenocarcinoma that focally looks like a sex cord-stromal tumor with sertoli, leydig, or granulosa cells. The histologic similarities of SEC and SLTs can be confusing even to experienced consultants. Ordi et al., in their study, reported that SEC typically demonstrates the following characteristics, while SLTs do not: (1) Presence of areas with usual pattern of endometrioid carcinoma, (2) presence of mucin at the apical borders of the tumor cells. [3]

Other factors that may favor SEC would include squamous or squamoid areas, well-developed cilia, the presence of endometriosis, or a concomitant adenocarcinoma of the endometrium. [4]

IHC is of great value in the differential diagnosis. Immunostains for alpha-inhibin is positive in most neoplastic  Sertoli cells More Details but negative in the cells of endometrioid carcinoma, while positive EMA and CK immunostains favor SEC. [5]

Despite histologic similarity, there are important clinical differences between the SEC and SLT patient populations. Misir and Sur in their study report that in SLTs, the patient age tends to be younger, with an average age of 25 years and clinically, up to 50% of SLT patients may exhibit endocrine manifestations. In contrast, SEC occurs almost exclusively in postmenopausal women with an average age of 68 years. Virilizing symptoms, though uncommon in endometrioid carcinoma, may be encountered in the sertoliform variant, thus compounding the diagnostic difficulty. [6] In our case, the patient was in her postmenopause with no signs of virilization. She had SEC and presented with torsion which is extremely rare.

Recognition of SEC is important for grading of endometrioid adenocarcinoma. Usually, solid portion of endometrioid adenocarcinoma is considered as Grade 3 according to the International Federation of Obstetrics and Gynecologists grading system. [7] SEC should be considered as Grade 1 (well-differentiated), despite the presence of solid, sex cord-like proliferation as it carries good prognosis when confined to ovary. [1],[3] According to these suggestions, our case is graded as well-differentiated (Grade 1) based on the histological features of foci of conventional endometrioid carcinoma. Patient is kept under close follow-up for any recurrence.


   Conclusion Top


The case is presented for its rarity. In view of relatively good prognosis of SEC as compared to Endometrioid tumor, identifying this variant by an extensive sampling of the specimen is mandatory.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Misir A, Sur M. Sertoliform endometrioid carcinoma of the ovary: A potential diagnostic pitfall. Arch Pathol Lab Med 2007;131:979-81.  Back to cited text no. 1
    
2.
Bakshi N, Gupta N, Mahajan V. Ovarian sertoliform endometrioid carcinoma: A diagnostic dilemma. Indian J Pathol Microbiol 2013;56:327-8.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.
Ordi J, Schammel DP, Rasekh L, Tavassoli FA. Sertoliform endometrioid carcinomas of the ovary: A clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 1999;12:933-40.  Back to cited text no. 3
    
4.
Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking sertoli and sertoli-leydig cell tumors: Sertoliform variant of endometrioid carcinoma. Cancer 1982;50:1322-31.  Back to cited text no. 4
    
5.
Prat J. Ovarian carcinomas, including secondary tumors: Diagnostically challenging areas. Mod Pathol 2005;18 Suppl 2:S99-111.  Back to cited text no. 5
    
6.
Seidman JD, Russel P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman R, editor. Blaustein′s Pathology of the Female Genital Tract. 5 th ed. New York: Springer-Verlag Inc.; 2002. p. 791-886.  Back to cited text no. 6
    
7.
Zaino RJ, Kurman RJ, Diana KL, Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 1995;75:81-6.  Back to cited text no. 7
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]



 

Top
 
 
  Search
 
  
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Case Report
   Discussion
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed1520    
    Printed31    
    Emailed0    
    PDF Downloaded85    
    Comments [Add]    

Recommend this journal